News Archive
Nathaniel DeNicola, MD, co-authored a review article on environmental exposures on reproductive health and how OB-GYNs can work with their patients to ensure safe pregnancies. The piece is published in Obstetrics and Gynecology Clinics of North America.
During a symposium on correctional policy, practice, and care for incarcerated members of the transgender community, held at the GW, stakeholders found that collaborative engagement could help further guidance for this vulnerable population.
Faculty at the George Washington University School of Medicine and Health Sciences (SMHS) will take part in the American College of Rheumatology’s (ACR) 2019 Annual Meeting in November in Atlanta.
Rachel Brem, MD, director of breast imaging and intervention at the GW Cancer Center and professor of radiology as SMHS, spoke to Today.com for an article discussing what women under 40 should do to detect breast cancer.
Jeffrey S. Akman, MD ’81, RESD ’85, vice president for health affairs, Walter A. Bloedorn Professor of Administrative Medicine, and dean of SMHS, delivered the annual State of the School address during Reunion Weekend on Sept. 14, offering attendees an overview of the progress that has been made…
A new tradition at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) began on Sept. 19, as members of the school’s faculty gathered to be honored for their years of service, commitment to the institution, and great achievements made while working at SMHS.
The GW School of Medicine and Health Sciences inducted members of the MD Class of 1969 into the H Street Society during MD Reunion Weekend.
The AIDS and Cancer Specimen Resource has been renewed for five years with GW serving as the primary site.
In early September, students participated in SMHS Community Service Day, a chance to learn more about needs in Washington, D.C., and discover ways they can give back as members of this vibrant city.
GW Cancer Center researchers found that PTEN, a tumor suppressor gene mutated in approximately 20% of primary prostate cancers, and in as many as 50% of androgen deprivation-resistant prostate cancers, relies on another gene, ARID4B, to function.